JP2022547786A5 - - Google Patents
Info
- Publication number
- JP2022547786A5 JP2022547786A5 JP2022506337A JP2022506337A JP2022547786A5 JP 2022547786 A5 JP2022547786 A5 JP 2022547786A5 JP 2022506337 A JP2022506337 A JP 2022506337A JP 2022506337 A JP2022506337 A JP 2022506337A JP 2022547786 A5 JP2022547786 A5 JP 2022547786A5
- Authority
- JP
- Japan
- Prior art keywords
- vector
- nucleic acid
- acid sequence
- sequence
- adenovirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025029451A JP2025084850A (ja) | 2019-07-29 | 2025-02-26 | ハンタウイルス抗原性組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1910804.2A GB201910804D0 (en) | 2019-07-29 | 2019-07-29 | Hantavirus antigenic Composition |
| GB1910804.2 | 2019-07-29 | ||
| PCT/GB2020/051813 WO2021019235A2 (en) | 2019-07-29 | 2020-07-29 | Hantavirus antigenic composition |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025029451A Division JP2025084850A (ja) | 2019-07-29 | 2025-02-26 | ハンタウイルス抗原性組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022547786A JP2022547786A (ja) | 2022-11-16 |
| JP2022547786A5 true JP2022547786A5 (https=) | 2023-07-11 |
| JP7642608B2 JP7642608B2 (ja) | 2025-03-10 |
Family
ID=67990345
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022506337A Active JP7642608B2 (ja) | 2019-07-29 | 2020-07-29 | ハンタウイルス抗原性組成物 |
| JP2025029451A Pending JP2025084850A (ja) | 2019-07-29 | 2025-02-26 | ハンタウイルス抗原性組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025029451A Pending JP2025084850A (ja) | 2019-07-29 | 2025-02-26 | ハンタウイルス抗原性組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220275346A1 (https=) |
| EP (1) | EP4003413A2 (https=) |
| JP (2) | JP7642608B2 (https=) |
| KR (1) | KR20220038755A (https=) |
| CN (2) | CN114269939B (https=) |
| GB (1) | GB201910804D0 (https=) |
| WO (1) | WO2021019235A2 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113234129B (zh) * | 2021-05-08 | 2023-02-07 | 中国人民解放军空军军医大学 | Hla-e限制性htnv结构蛋白特异性cd8+t细胞表位肽及其聚合物和应用 |
| US20250127870A1 (en) * | 2021-09-16 | 2025-04-24 | Board Of Regents, The University Of Texas System | mRNA Vaccines Against Hantavirus |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4473497A (en) * | 1996-10-04 | 1998-04-24 | Cheil Jedang Corporation | Nucleocapsid gene of seoul virus r22, recombinant plasmid, transformed e. coli and diagnostic agent and vaccine for haemorrhagic fever with renal syndrome |
| DE60029928D1 (de) | 1999-01-29 | 2006-09-21 | U S Medical Res Inst Of Infect | Dna impfstoffe gegen hantavirus infektionen |
| CN101163498B (zh) | 2004-06-18 | 2011-10-05 | 诺华疫苗和诊断公司 | 用于诊断汉他病毒感染的方法和试剂 |
| WO2006022461A1 (en) | 2004-08-27 | 2006-03-02 | Nexgen Biotechnologies, Inc. | Diagnosis kits for hemorrhagic fever with renal syndrome comprising nucleocapsid protein of hanta virus expressed in transformed plant |
| US11602557B2 (en) * | 2017-08-22 | 2023-03-14 | Cure Vac SE | Bunyavirales vaccine |
-
2019
- 2019-07-29 GB GBGB1910804.2A patent/GB201910804D0/en not_active Ceased
-
2020
- 2020-07-29 EP EP20751639.4A patent/EP4003413A2/en active Pending
- 2020-07-29 CN CN202080054858.XA patent/CN114269939B/zh active Active
- 2020-07-29 US US17/631,416 patent/US20220275346A1/en active Pending
- 2020-07-29 WO PCT/GB2020/051813 patent/WO2021019235A2/en not_active Ceased
- 2020-07-29 KR KR1020227006458A patent/KR20220038755A/ko active Pending
- 2020-07-29 CN CN202411481536.XA patent/CN119144656A/zh active Pending
- 2020-07-29 JP JP2022506337A patent/JP7642608B2/ja active Active
-
2025
- 2025-02-26 JP JP2025029451A patent/JP2025084850A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100379865C (zh) | 用于产生cd8t细胞免疫应答的试剂盒及其用途 | |
| CN111315407B (zh) | 一种广谱抗流感疫苗免疫原及其应用 | |
| JP2019526580A5 (https=) | ||
| JP2013507907A5 (https=) | ||
| JP2020031658A5 (https=) | ||
| JP2014534202A5 (https=) | ||
| Wang et al. | Recombinant adenovirus expressing F and H fusion proteins of peste des petits ruminants virus induces both humoral and cell-mediated immune responses in goats | |
| RU2011104999A (ru) | Варианты гемагглютинина и нейрамидазы вируса гриппа | |
| JP2015524794A5 (https=) | ||
| JP2016510989A5 (https=) | ||
| JP2020531032A5 (https=) | ||
| RU2019144161A (ru) | Последовательности нуклеиновых кислот и аминокислотные последовательности аденовирусов человекообразных обезьян, исключая человека, содержащие их векторы и их применения | |
| JP2020511114A5 (https=) | ||
| Legrand et al. | Induction of potent humoral and cell-mediated immune responses by attenuated vaccinia virus vectors with deleted serpin genes | |
| JP2011500718A5 (https=) | ||
| IL276210B2 (en) | Mers-cov vaccine | |
| JP2015186478A5 (https=) | ||
| JP2018524977A5 (https=) | ||
| RU2016131853A (ru) | Гибридизация гетероолигомерных микобактериальных антигенов | |
| JP2025084850A5 (https=) | ||
| JP2014207903A5 (https=) | ||
| JP2022547786A5 (https=) | ||
| JP2024105526A5 (https=) | ||
| RU2016133598A (ru) | Композиция микобактериального антигена | |
| JP2020533411A5 (https=) |